The U.S. mhealth apps market size was worth USD 12.38 billion in 2024 and is estimated to reach USD 13.77 billion in 2025 to approximately USD 35.79 billion by 2034, growing at a CAGR of 11.2% over the forecast period. The rising smartphone adoption, patient demand for digital health solutions, and managing long-term health conditions are vital uses, driving the market growth.
.webp)
The U.S. mHealth apps market
The U.S. mHealth Apps market comprises mobile health applications, which are smartphone features that are designed to support and improve various aspects of health and healthcare. This app provides health-related services and improves health outcomes, and delivers health care services. These apps are various applications, such as appointment scheduling, heart rate monitoring, calorie intake tracking, and water consumption tracking. The market growth is driven by a user-friendly interface that is easy to navigate, promotes engagement, and is accessible to different types of users. Wearable medical technology accurately monitors fitness, heart rate, general wellness, and disease management. Offering user personalized user experience helps improve user activities and outcomes.
The rising smartphone penetration and integration with ecosystem modern smartphones are central hubs that integrate with other advanced technologies, including wearable health monitors, AI, and telehealth platforms. This connectivity enables apps to gather and analyze continuous, real-time health data, providing more accurate and personalized recommendations. High smartphone usage encourages a shift towards more patient-centered care models. mHealth apps give direct access to their health records, medication reminders, and wellness programs, empowering them to take a more active and proactive role in their own care. The rising prevalence of chronic diseases, such as diabetes, cardiovascular disease, and obesity, has led to a greater need for long-term health management. The integration of advanced technologies, such as Artificial Intelligence and Machine Learning, is enabling personalized and predictive health recommendations. Rising consumer demand for remote and personalized care drives market growth.
| Report Coverage | Details |
| Market Size in 2024 | USD 12.38 billion |
| Revenue Forecast by 2034 | USD 35.79 billion |
| Growth rate from 2025 to 2034 | CAGR of 11.2% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Companies Covered | Apple Inc., Google LLC, Samsung Electronics Co., Ltd., Fitbit, Inc. MyFitnessPal, Inc., Teladoc Health, Inc., Medisafe Limited, Johnson & Johnson, Ada Health GmbH, Noom, Inc., AliveCor, Inc., WellDoc, Inc., HealthTap, Inc. |
Several key factors are contributing to the robust growth of the U.S. mHealth apps market. One of the primary drivers is the widespread use of smartphones and increasing internet penetration, which have made mobile health solutions more accessible to a large segment of the population. Consumers are becoming more health-conscious and are turning to mobile apps for fitness tracking, diet planning, medication reminders, and chronic disease management. Additionally, the growing burden of lifestyle-related diseases such as diabetes, hypertension, and obesity is pushing both patients and healthcare providers to adopt digital tools for real-time monitoring and better disease management.
Another significant growth factor is the rising integration of advanced technologies such as artificial intelligence (AI), machine learning, and wearable device connectivity within mHealth apps. These innovations are enabling personalized healthcare experiences and more accurate health tracking.
Expansion into chronic disease management
The aging population and increases in lifestyle-related diseases have made chronic disease management a critical area of concern. In the U.S., a high percentage of adults have one or more chronic conditions, which drive the demand for cost-effective and accessible management tools. The growing shift towards patient-centric care empowers individuals to take an active role in their health.
Rising adoption of AI and ML
The increasing use of Artificial Intelligence and Machine Learning to analyze collected health data, and mHealth apps to facilitate virtual consultation and secure communication between patients and healthcare providers. It enables personalized health recommendations and improves diagnostic and treatment outcomes.
Privacy and security issues, and a lack of clinical validation and regulatory oversight
The widespread data leakage of the mHealth apps tested could be accessed. Many health apps lack robust security and privacy protection. Some apps transmit unencrypted sensitive data over the internet, making it vulnerable to interception by malicious parties, especially on public Wi-Fi networks. The Insurance Portability and Accountability Act does not apply to all health apps. The lack of formal evaluation and review by medical professionals and regulatory bodies makes providers hesitant to recommend apps. They are often concerned that the apps could offer incorrect or misleading information and lead to misdiagnosis or delayed treatment.
How did the Medical Apps Segment Dominate the U.S. mHealth Apps Market in 2024?
The medical apps segment held the largest share of the market, accounting for 72% of the total revenue in 2024. The medical apps are increasingly becoming integrated with electronic health records and support virtual consultation, allowing seamless communication and information sharing between patients and providers. The rising prevalence of chronic diseases, such as diabetes and hypertension, drives the need for digital tools that enable patient to monitor vital signs, track medication, and manage their conditions effectively. The shift towards value-based care and remote monitoring in the U.S. healthcare system is moving towards value-based care and remote monitoring, making medical apps essential for improving patient outcomes and potentially reducing healthcare costs.
The medical app segment is expected to grow at a notable rate during the predicted timeframe, owing to the integration of AI and technological advancements with electronic health records is enhancing the functionality and clinical utility of these applications. The government initiatives, such as expanded telehealth coverage and reimbursement policies, encourage broader adoption of digital health services. The rising number of new features and easy availability of many medical apps in the market are boosting the demand. The rising awareness of medical apps drives the market growth.
Why does the iOS Segment Dominate the U.S. mHealth Apps Market by Platform?
The iOS segment led the market in 2024, capturing a revenue share of 53%. due to its HealthKit allows apps to securely read and write health and fitness data from the iPhone and Apple Watch, creating a centralized hub for personal health information. Health records API features allow users to directly connect and download their clinical health records from supported healthcare institutions, which are then securely stored within the health app. iOS uses multiple encryption protocols to protect health data. Apple's rigorous approval process for the App Store ensures a higher standard of quality and security for mHealth applications.
The Android segment is expected to grow at a notable rate as the various income levels expand access to mHealth apps for a broader user base in the U.S. The flexible and innovative development to innovate and customize app functionalities. The development of diverse mHealth solutions for specific medical and wellness needs, including scalable public health initiatives and advanced telehealth options. The strong wearable device integration by improved security features and seamless integration with Google Fit and many wearable devices. The rising developer investment, seamless ecosystem integration drive the market growth.
The U.S. mHealth app market is highly focused on integrating advanced technologies like AI, machine learning, and IoT to create more personalized, secure, and effective digital therapeutics and remote monitoring tools. However, this rapid innovation faces significant hurdles, including complex regulations, data security vulnerabilities, and challenges in clinical validation.
The U.S. mHealth app market offers a comprehensive suite of patient support and services designed to improve engagement, manage chronic conditions, and provide more accessible care. By leveraging telemedicine, real-time monitoring, and secure communication, mHealth apps empower patients to take a more active role in their health management.
The Food and Drug Administration (FDA) plays a key role in ensuring the safety and effectiveness of certain apps. Not all mHealth apps require FDA approval; the need for approval depends primarily on the app's intended use and its potential risk to patient safety.
By Type
By Platform
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. mHealth Apps Market
5.1. COVID-19 Landscape: U.S. mHealth Apps Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. mHealth Apps Market, By Type
8.1. U.S. mHealth Apps Market, by Type, 2024-2033
8.1.1. Medical Apps
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Fitness Apps
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. U.S. mHealth Apps Market, By Platform
9.1. U.S. mHealth Apps Market, by Platform, 2024-2033
9.1.1. Android
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. iOS
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 10. U.S. mHealth Apps Market, Regional Estimates and Trend Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by January
11.1.2. Market Revenue and Forecast, by February
Chapter 11. Company Profiles
11.1. Apple Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Google LLC
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Samsung Electronics Co., Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Fitbit, Inc. (Now part of Google)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. MyFitnessPal, Inc.
11.5. Intermountain Life Sciences
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Teladoc Health, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Medisafe Limited
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Johnson & Johnson
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Ada Health GmbH
11.9. Evoqua Water Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Noom, Inc.
11.10. Nexus Pharmaceuticals
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms